53 related articles for article (PubMed ID: 3652040)
1. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.
Boothman DA; Greer S; Pardee AB
Cancer Res; 1987 Oct; 47(20):5361-6. PubMed ID: 3652040
[TBL] [Abstract][Full Text] [Related]
2. The shaping of a molecular linguist: How a career studying DNA energetics revealed the language of molecular communication.
Breslauer KJ
J Biol Chem; 2021; 296():100522. PubMed ID: 34237886
[TBL] [Abstract][Full Text] [Related]
3. Targeting Base Excision Repair in Cancer: NQO1-Bioactivatable Drugs Improve Tumor Selectivity and Reduce Treatment Toxicity Through Radiosensitization of Human Cancer.
Starcher CL; Pay SL; Singh N; Yeh IJ; Bhandare SB; Su X; Huang X; Bey EA; Motea EA; Boothman DA
Front Oncol; 2020; 10():1575. PubMed ID: 32974194
[TBL] [Abstract][Full Text] [Related]
4. NQO1-dependent, Tumor-selective Radiosensitization of Non-small Cell Lung Cancers.
Motea EA; Huang X; Singh N; Kilgore JA; Williams NS; Xie XJ; Gerber DE; Beg MS; Bey EA; Boothman DA
Clin Cancer Res; 2019 Apr; 25(8):2601-2609. PubMed ID: 30617135
[TBL] [Abstract][Full Text] [Related]
5. Targeting NAD
Lewis JE; Singh N; Holmila RJ; Sumer BD; Williams NS; Furdui CM; Kemp ML; Boothman DA
Semin Radiat Oncol; 2019 Jan; 29(1):6-15. PubMed ID: 30573185
[TBL] [Abstract][Full Text] [Related]
6. NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity.
Kim DW; Cho JY
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513573
[TBL] [Abstract][Full Text] [Related]
7. Modulators of Redox Metabolism in Head and Neck Cancer.
Chen X; Mims J; Huang X; Singh N; Motea E; Planchon SM; Beg M; Tsang AW; Porosnicu M; Kemp ML; Boothman DA; Furdui CM
Antioxid Redox Signal; 2018 Dec; 29(16):1660-1690. PubMed ID: 29113454
[TBL] [Abstract][Full Text] [Related]
8. Genome-Scale Modeling of NADPH-Driven β-Lapachone Sensitization in Head and Neck Squamous Cell Carcinoma.
Lewis JE; Costantini F; Mims J; Chen X; Furdui CM; Boothman DA; Kemp ML
Antioxid Redox Signal; 2018 Oct; 29(10):937-952. PubMed ID: 28762750
[TBL] [Abstract][Full Text] [Related]
9. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.
Gunda V; Souchek J; Abrego J; Shukla SK; Goode GD; Vernucci E; Dasgupta A; Chaika NV; King RJ; Li S; Wang S; Yu F; Bessho T; Lin C; Singh PK
Clin Cancer Res; 2017 Oct; 23(19):5881-5891. PubMed ID: 28720669
[No Abstract] [Full Text] [Related]
10. Focal Adhesion Kinase Regulates the DNA Damage Response and Its Inhibition Radiosensitizes Mutant KRAS Lung Cancer.
Tang KJ; Constanzo JD; Venkateswaran N; Melegari M; Ilcheva M; Morales JC; Skoulidis F; Heymach JV; Boothman DA; Scaglioni PP
Clin Cancer Res; 2016 Dec; 22(23):5851-5863. PubMed ID: 27220963
[TBL] [Abstract][Full Text] [Related]
11. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Li LS; Reddy S; Lin ZH; Liu S; Park H; Chun SG; Bornmann WG; Thibodeaux J; Yan J; Chakrabarti G; Xie XJ; Sumer BD; Boothman DA; Yordy JS
Mol Cancer Ther; 2016 Jul; 15(7):1757-67. PubMed ID: 27196777
[TBL] [Abstract][Full Text] [Related]
12. Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways.
Chakrabarti G; Gerber DE; Boothman DA
Clin Pharmacol; 2015; 7():57-68. PubMed ID: 25870517
[TBL] [Abstract][Full Text] [Related]
13. Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation.
Souchek JJ; Baine MJ; Lin C; Rachagani S; Gupta S; Kaur S; Lester K; Zheng D; Chen S; Smith L; Lazenby A; Johansson SL; Jain M; Batra SK
Br J Cancer; 2014 Sep; 111(6):1139-49. PubMed ID: 25025965
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screen of natural product libraries for hsp90 inhibitors.
Davenport J; Balch M; Galam L; Girgis A; Hall J; Blagg BS; Matts RL
Biology (Basel); 2014 Feb; 3(1):101-38. PubMed ID: 24833337
[TBL] [Abstract][Full Text] [Related]
15. Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
Cao L; Li LS; Spruell C; Xiao L; Chakrabarti G; Bey EA; Reinicke KE; Srougi MC; Moore Z; Dong Y; Vo P; Kabbani W; Yang CR; Wang X; Fattah F; Morales JC; Motea EA; Bornmann WG; Yordy JS; Boothman DA
Antioxid Redox Signal; 2014 Jul; 21(2):237-50. PubMed ID: 24512128
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.
Dong Y; Bey EA; Li LS; Kabbani W; Yan J; Xie XJ; Hsieh JT; Gao J; Boothman DA
Cancer Res; 2010 Oct; 70(20):8088-96. PubMed ID: 20940411
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of ionizing radiation and beta-Lapachone against RKO human colon adenocarcinoma cells.
Kim EJ; Ji IM; Ahn KJ; Choi EK; Park HJ; Lim BU; Song CW; Park HJ
Cancer Res Treat; 2005 Jun; 37(3):183-90. PubMed ID: 19956501
[TBL] [Abstract][Full Text] [Related]
18. Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.
Konstantinidou G; Bey EA; Rabellino A; Schuster K; Maira MS; Gazdar AF; Amici A; Boothman DA; Scaglioni PP
Cancer Res; 2009 Oct; 69(19):7644-52. PubMed ID: 19789349
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells.
Choi EK; Terai K; Ji IM; Kook YH; Park KH; Oh ET; Griffin RJ; Lim BU; Kim JS; Lee DS; Boothman DA; Loren M; Song CW; Park HJ
Neoplasia; 2007 Aug; 9(8):634-42. PubMed ID: 17786182
[TBL] [Abstract][Full Text] [Related]
20. New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors.
Bentle MS; Bey EA; Dong Y; Reinicke KE; Boothman DA
J Mol Histol; 2006 Sep; 37(5-7):203-18. PubMed ID: 16868862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
